Tradestie Institutional Equity Comparison Engine

UL vs CLX โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

CLX Overall Edge

CLX Captures Institutional Edge (3โ€“1 Pillars ยท 4โ€“6 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Clorox Company (CLX) driven by superior Valuation, Momentum & Technical, Options & Structure while UL counters with relative strength in Growth & Margin. Fundamentally, UL trades at 18.5x Forward P/E with 20.0% operating margin (+0.5% YoY revenue) versus CLX at 17.6x Forward P/E and 14.3% operating margin (+33.3% YoY). In options structure, UL sits in UNCLASSIFIED (13th %ile IV; Dealer Gamma Walls on Pro) against CLX sits in SURGE (25th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner CLX
UL 18.5x vs CLX 17.6x Fwd P/E
Growth & Margin Winner UL
Op Margin 20.0% vs 14.3% ยท YoY +0.5% vs +33.3%
Momentum & Technical Winner CLX
1Y +8.4% vs +6.4% ยท 52W Pos 45% vs 51%
Options & Structure Winner CLX
UNCLASSIFIED (13th %ile IV) vs SURGE (25th %ile IV)
UL NYSE
Unilever plc
Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics
$63.82
+0.73% 1D
Market Cap $136.4B
1M Return -4.75%
1Y Return +8.41%
Forward P/E 18.5x
Unified AI Score
46.7 / 100 HOLD
Tech 47.0 Fund 45.0 Flow 50.0 Mom 36.0
CLX NYSE
Clorox Company
Specialty Cleaning, Polishing And Sanitation Preparations
$104.73
-0.16% 1D
Market Cap $12.7B
1M Return +18.13%
1Y Return +6.4%
Forward P/E 17.6x
Unified AI Score
29.7 / 100 SELL
Tech 50.0 Fund 32.0 Flow 57.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: UL +8.41% CLX +6.4% Spread: +2.01 pp (UL Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
UL TTM Op. Margin: 20.0% CLX TTM Op. Margin: 14.3%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on UL vs CLX. Trailing 12-month operating profitability (UL 20.0% vs CLX 14.3%) and valuation multiples (UL 18.5x vs CLX 17.6x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: UL (6) vs CLX (4)
Institutional Metric UL CLX Criterion Row Winner
Market Capitalization Scale $136.4B $12.7B Larger Scale UL
Trailing P/E Ratio Valuation 13.0x 18.9x Lower Multiple UL
Forward P/E Ratio Valuation 18.5x 17.6x Lower Multiple CLX
Revenue Growth (YoY) Growth +0.5% +33.3% Higher Growth CLX
Operating Margin (TTM) Profitability 20.0% 14.3% Higher Margin UL
Net Profit Margin Profitability 18.3% 9.4% Higher Margin UL
Return on Equity (ROE) Capital Efficiency 31.9% 53.4% Higher ROE CLX
52-Week Range Position Momentum 45% ($55โ€“$75) 51% ($79โ€“$129) Stronger Trend CLX
Beta / 30D Volatility Risk Regime -0.03ฮฒ ยท 24% Vol 0.43ฮฒ ยท 37% Vol Lower Realized Risk UL
Unified Institutional Score Composite Signal 46.7 / 100 (HOLD) 29.7 / 100 (SELL) Higher Composite UL

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full UL vs CLX Buy Guide
UL UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 13th %ile
IV Regime Compressed (<25th %ile)
Live UL Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
CLX SURGE
5d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 25th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live CLX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither UL nor CLX registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.